Status:
COMPLETED
Integrated Exercise Program in Opioid Agonist Therapy Clinics
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
Helse Stavanger HF
Helse Vest
Conditions:
Substance-Related Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Drug use is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. Particular people with opioid dependence have high morbidity and reduced quali...
Detailed Description
See below each section
Eligibility Criteria
Inclusion
- Receiving OAT from an included outpatient clinic with follow-up weekly
- Low level of physical activity measured using IPAQ (assessed at screening)
- Confirming interest in participating in physical activity intervention and providing informed consent (criteria specified)
- Giving informed consent
Exclusion
- Not able to participate in the intervention due to physical disabilities or severe mental disorders
- Being imprisoned or in inpatient treatment settings
Key Trial Info
Start Date :
April 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
309 Patients enrolled
Trial Details
Trial ID
NCT05242848
Start Date
April 7 2022
End Date
March 1 2025
Last Update
August 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
LAR Helse Stavanger HF
Stavanger, Rogaland, Norway, 4010
2
Department of Addiction Medicine, Haukeland University Hospital
Bergen, Vestland, Norway, 5020